Kate Smith
The guest speaker on Monday, December 16, 2013, will be Kapil Lotun, MD; this free presentation will be at 9:00 a.m. in the Madera Clubhouse Crystal Ballroom.
Dr. Kapil Lotun joined the University of Arizona and the Sarver Heart Center in August 2011 as associate professor of Clinical Medicine, Cardiology. Dr. Lotun is Director of Structural Heart Disease and Vascular Medicine within the Division of Cardiology. He is also the Medical Director for the TAVR program.
Dr. Lotun received his vascular medicine, cardiology training and interventional cardiology fellowship training at the Tufts University School of Medicine in Boston.
His clinical expertise includes structural heart disease such as aortic valvuloplasty, repairing stenotic or hardened aortic valves using balloon catheters. He also treats congenital heart defects, such as a ventricular septal defect, or a hole in the heart, patent foramen ovale, tissue flaps in the heart that don’t close properly, and atrial septal defect closure, where a hole in the wall between the two upper chambers remains open after birth allowing blood to flow and causing pressure in the lungs. His specialty is in percutaneous procedures in which he uses small needle catheters to treat aortic and mitral valve disease and vascular diseases. These catheters also are used in endovascular interventions for vascular diseases and high risk coronary procedures.
Dr. Lotun is a fellow of American College of Cardiology, the Society of Vascular Medicine and the Society for Cardiovascular Angiography and Interventions. He is board certified in internal medicine, endovascular medicine, vascular medicine, echocardiography, nuclear cardiology, cardiology and interventional cardiology. He also is a registered vascular technologist.
Dr. Lotun’s research involves gene therapy in cardiac and vascular diseases. He has been co investigator on several related NIH trials and investigations and has given presentations at the American Heart Association Scientific Sessions, Society of Cardiac Angiography and Interventions and the Society of Vascular Medicine Meetings. He has published in various professional journals and has contributed to two book chapters on cardiovascular gene therapy. He is a reviewer for multiple journals including Catheterization and Cardiovascular Interventions, JACC Intervention and Annals of Vascular Surgery.